Pfizer Files 10-Q for Q3 2024
Ticker: PFE · Form: 10-Q · Filed: 2024-11-04T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
Pfizer's Q3 2024 10-Q is in. Check financials.
AI Summary
Pfizer Inc. filed its 10-Q for the period ending September 29, 2024. The filing covers the third quarter and the first nine months of the fiscal year. Key financial data and operational details for this period are presented, reflecting the company's performance in the pharmaceutical sector.
Why It Matters
This filing provides investors and analysts with crucial financial and operational updates for Pfizer, impacting investment decisions and market perception of the pharmaceutical giant.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing and does not inherently present new risks.
Key Players & Entities
- Pfizer Inc. (company) — Filer of the 10-Q
- 20240929 (date) — End of reporting period
- 20241104 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is September 29, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on November 4, 2024.
What is Pfizer Inc.'s Standard Industrial Classification code?
Pfizer Inc.'s Standard Industrial Classification code is 2834, for Pharmaceutical Preparations.
What is the fiscal year end for Pfizer Inc.?
Pfizer Inc.'s fiscal year ends on December 31.
What is the business address listed for Pfizer Inc.?
The business address listed for Pfizer Inc. is 66 Hudson Boulevard East, New York, NY 10001-2192.
From the Filing
0000078003-24-000191.txt : 20241104 0000078003-24-000191.hdr.sgml : 20241104 20241104160608 ACCESSION NUMBER: 0000078003-24-000191 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 103 CONFORMED PERIOD OF REPORT: 20240929 FILED AS OF DATE: 20241104 DATE AS OF CHANGE: 20241104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 241423491 BUSINESS ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 BUSINESS PHONE: 2127332323 MAIL ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 10-Q 1 pfe-20240929.htm 10-Q pfe-20240929 0000078003 12/31 2024 Q3 false xbrli:shares iso4217:USD iso4217:USD xbrli:shares pfe:operatingSegment xbrli:pure pfe:facility pfe:patent pfe:treatmentCourse 0000078003 2024-01-01 2024-09-29 0000078003 us-gaap:CommonStockMember 2024-01-01 2024-09-29 0000078003 pfe:NotesDue20271.000Member 2024-01-01 2024-09-29 0000078003 2024-10-30 0000078003 us-gaap:ProductMember 2024-07-01 2024-09-29 0000078003 us-gaap:ProductMember 2023-07-03 2023-10-01 0000078003 us-gaap:ProductMember 2024-01-01 2024-09-29 0000078003 us-gaap:ProductMember 2023-01-01 2023-10-01 0000078003 2024-07-01 2024-09-29 0000078003 2023-07-03 2023-10-01 0000078003 2023-01-01 2023-10-01 0000078003 us-gaap:RoyaltyMember 2024-07-01 2024-09-29 0000078003 us-gaap:RoyaltyMember 2023-07-03 2023-10-01 0000078003 us-gaap:RoyaltyMember 2024-01-01 2024-09-29 0000078003 us-gaap:RoyaltyMember 2023-01-01 2023-10-01 0000078003 2024-09-29 0000078003 2023-12-31 0000078003 us-gaap:CommonStockMember 2024-06-30 0000078003 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000078003 us-gaap:TreasuryStockCommonMember 2024-06-30 0000078003 us-gaap:RetainedEarningsMember 2024-06-30 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000078003 us-gaap:ParentMember 2024-06-30 0000078003 us-gaap:NoncontrollingInterestMember 2024-06-30 0000078003 2024-06-30 0000078003 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-29 0000078003 us-gaap:ParentMember 2024-07-01 2024-09-29 0000078003 us-gaap:NoncontrollingInterestMember 2024-07-01 2024-09-29 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-29 0000078003 us-gaap:CommonStockMember 2024-07-01 2024-09-29 0000078003 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-29 0000078003 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-29 0000078003 us-gaap:CommonStockMember 2024-09-29 0000078003 us-gaap:AdditionalPaidInCapitalMember 2024-09-29 0000078003 us-gaap:TreasuryStockCommonMember 2024-09-29 0000078003 us-gaap:RetainedEarningsMember 2024-09-29 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-29 0000078003 us-gaap:ParentMember 2024-09-29 0000078003 us-gaap:NoncontrollingInterestMember 2024-09-29 0000078003 us-gaap:CommonStockMember 2023-07-02 0000078003 us-gaap:AdditionalPaidInCapitalMember 2023-07-02 0000078003 us-gaap:TreasuryStockCommonMember 2023-07-02 0000078003 us-gaap:RetainedEarningsMember 2023-07-02 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-02 0000078003 us-gaap:ParentMember 2023-07-02 0000078003 us-gaap:NoncontrollingInterestMember 2023-07-02 0000078003 2023-07-02 0000078003 us-gaap:RetainedEarningsMember 2023-07-03 2023-10-01 0000078003 us-gaap:ParentMember 2023-07-03 2023-10-01 0000078003 us-gaap:NoncontrollingInterestMember 2023-07-03 2023-10-01 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-03 2023-10-01 0000078003 us-gaap:CommonStockMember 2023-07-03 2023-10-01 0000078003 us-gaap:AdditionalPaidInCapitalMember 2023-07-03 2023-10-01 00000780